Columbus Venture Partners
Columbus Venture Partners is a Spanish independent venture capital that brings a unique approach for investing in outstanding early-stage and high growth opportunities in the life science industry of Spain.
Our team includes solid and internationally experienced investment professionals with a deep scientific, medical and business development background combined with a proven experience in building and investing in companies to accelerate their commercialization.
The combination of industry possibilities and investment experience will provide Limited Partner investors in the Fund a level of professionality and deep expertise that is essential for success in this field.
WHY COLUMBUS VENTURES PARTNERS
Christopher Columbus, one of the great entrepreneurs who changed the history of mankind, always thought big. A true visionary, Columbus was resilient, able to adapt to challenges, and willing to take risks. Five hundred years ago, Columbus spent seven years pitching his business plan to Genoese bankers (the world’s first angel networks) before convincing Castile’s King Ferdinand and Queen Isabella to fund his crackpot scheme. This resulted in the world´s first term-sheet “Capitulations of Santa Fe”. This venture capital project resulted in a discovery that changed the fate of the world.
HOPE ACCELERATES HERE
At Columbus Venture Partners we believe that innovation has a real impact on society and, in particular, on those with the greatest needs. However, pharmaceutical developments focus on indications or diseases that, due to the number of patients, have a positive economic return potential on the executed investment. Therefore, ultra-rare disease treatments are often hampered not for technical reasons but for cost-effectiveness. For that reason, our goal from Columbus is to bring these cutting-edge innovations forward so that research and development of treatments for these ultra-rare diseases advance at the same rate as other larger indications. Children with these diseases and their families need an urgently access to these transformative medicines. Most of them suffer from a severely altered lifestyle, and in many cases life expectancy is less than ten years. At Columbus Venture Partners we are deeply motivated by the urgent needs to ensure that no child is left behind. Thus, we work with the Columbus Foundation (Spain) and the Columbus Children Foundation (USA) in collaboration with Askbio and Viralgen to provide a solution to these diseases.
You can follow our activity at the Columbus Foundation (Spain) and the Columbus Children Foundation (USA).
Together we can change lives and ensure precious moments because every child deserves to live life to the fullest